Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)

Author: Malerba M.   Ponticiello A.   Radaeli A.   Bensi G.   Grassi V.  

Publisher: Elsevier

ISSN: 1094-5539

Source: Pulmonary Pharmacology & Therapeutics, Vol.17, Iss.1, 2004-02, pp. : 27-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content